Back to Search
Start Over
Maker Deeply Cuts Price Of Steep Cholesterol Drug
- Source :
- The New York Times. October 26, 2018, A14
- Publication Year :
- 2018
-
Abstract
- For years, the drug maker Amgen has struggled to sell its new anti-cholesterol drug, Repatha after insurers balked over the list price of about $14,000 a year. On Wednesday, Amgen [...]
Details
- Language :
- English
- ISSN :
- 03624331
- Database :
- Gale General OneFile
- Journal :
- The New York Times
- Publication Type :
- News
- Accession number :
- edsgcl.559794743